(RTTNews) – Deciphera Pharmaceuticals, and Ono Pharmaceutical Co. announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use has adopted a positive opinion recommending the approval of vimseltinib or ROMVIMZA for the treatment of adult patients